1. USFDA. Compliance Program Guidance Manual. Inspectional Chapter. Section D3. Available: http://www.fda.gov/downloads/ICECI/EnforcementActions/BioresearchMonitoring/ucm133773.pdf. Accessed 10 November 2013.
2. International Conference on Harmonisation. Guideline for good clinical practice E6 (R1), Current step 4 version.1996. Available: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf. Accessed 10 November 2013.
3. CDSCO.Good Clinical Practice Guidelines.2001. Available: http://rgcb.res.in/wp-content/uploads/2014/07/Good-Clinical-Practice-Guideline.pdf. Accessed 13 November 2013.
4. NIH IRB Professional Administrators Committee. Regulatory Process Workgroup Version. 2005. Available: https://www.genome.gov/Pages/Research/Intramural/IRB/Deviation_Violation_examples8-07.pdf. Accessed 13 November 2013.
5. Failure to report protocol violations in clinical trials; a threat to internal validity?;EA Sweetman;Trials,2011